Brydon L. Bennett

10.4k citations

62 papers · 8.8k indexed · 3 hit papers · h-index 35

Impact in

Cancer Research top 0.2%
- NF-κB Signaling Pathways
Immunology top 0.5%
- Immune Response and Inflammation
- interferon and immune responses
- Immune Cell Function and Interaction

Papers in

Cancer Research 23
- NF-κB Signaling Pathways 23
Immunology 22
- Immune Response and Inflammation 11
- Immune Cell Function and Interaction 4

Co-authors: Anthony M. Manning Brion W. Murray Frank Mercurio Yoshitaka Satoh David L. Boyle David B. Young Andrej Shevchenko Matthias Mann
Journals: The Journal of Immunology (4 papers)Journal of Biological Chemistry (4 papers)Transplantation (4 papers)Blood (4 papers)Journal of Clinical Investigation (3 papers)
Partner nations: United States Switzerland Japan

In The Last Decade

Brydon L. Bennett

60 papers receiving 8.6k citations

Hit Papers

align trajectories log scale

c-Jun N-terminal kinase is required for metalloproteinase expression and joint destruction in inflammatory arthritis 2001 · 691 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2001 Journal of Clinical Investigation
2001 Proceedings of the National Academy of Sciences
1997 Science

Peers

Countries citing papers authored by Brydon L. Bennett

Since Specialization

Citations

This map shows the geographic impact of Brydon L. Bennett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brydon L. Bennett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brydon L. Bennett more than expected).

Fields of papers citing papers by Brydon L. Bennett

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brydon L. Bennett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brydon L. Bennett. The network helps show where Brydon L. Bennett may publish in the future.

Co-authors

The 25 scholars most cited alongside Brydon L. Bennett, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Brydon L. Bennett Line = papers co-authored together Brydon L. Bennett links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Jun N-terminal kinase as a potential molecular target for prevention and treatment of dermal fibrosis Annals of the Rheumatic Diseases ·Nicole Reich, Michal Tomčík, Pawel Zerr, Veronika Lang, Clara Dees, Jérôme Avouac, Katrin Palumbo, Angelika Horn, Alfiya Akhmetshina, Christian Beyer, Weilin Xie, Brydon L. Bennett, Oliver Distler, Georg Schett, Jörg H. W. Distler	2012	55
2	Evaluation of JNK Blockade as an Early Intervention Treatment for Type 1 Diabetic Nephropathy in Hypertensive Rats American Journal of Nephrology ·Andy K. H. Lim, Y. Frank, David J. Nikolic‐Paterson, Elyce Ozols, Morag J. Young, Brydon L. Bennett, Glenn C. Friedman, Greg H. Tesch	2011	32
3	JNK signalling in human and experimental renal ischaemia/reperfusion injury Nephrology Dialysis Transplantation ·John Kanellis, F. Y., Rangi Kandane‐Rathnayake, John P. Dowling, Kevan R. Polkinghorne, Brydon L. Bennett, Glenn C. Friedman, David J. Nikolic‐Paterson	2010	38
4	Abstract #5236: Lenalidomide affects F-Actin cytoskeleton in mantle cell lymphoma cells in vitro Cancer Research ·Svetlana Gaidarova, Gordafaried Deyanat‐Yazdi, Brydon L. Bennett, Antonia Lopez‐Girona	2009	1
5	CC-4047 promotes Th1 cell differentiation and reprograms polarized human Th2 cells by enhancing transcription factor T-bet Clinical Immunology ·Weiming Xu, Maria Celeridad, Sabita Sankar, David R. Webb, Brydon L. Bennett	2008	22
6	Attenuation of Ozone-Induced Airway Inflammation and Hyper-Responsiveness by c-Jun NH2 Terminal Kinase Inhibitor SP600125 Journal of Pharmacology and Experimental Therapeutics ·Alison S. Williams, Razao Issa, Sum Yee Leung, Puneeta Nath, Gregory D. Ferguson, Brydon L. Bennett, Ian M. Adcock, Kian Fan Chung	2007	49
7	The design and synthesis of novel orally active inhibitors of AP-1 and NF-κB mediated transcriptional activation. SAR of In vitro and In vivo studies Bioorganic & Medicinal Chemistry Letters ·Moorthy S. S. Palanki, Paul Erdman, Minghuan Ren, Mark J. Suto, Brydon L. Bennett, Anthony M. Manning, Lynn J. Ransone, Cheryl Spooner, Sonal J. Desai, Arnie Ow, Ryuichi Totsuka, Peter Tsao, Wataru Toriumi	2003	32
8	Allergen‐induced inflammation and airway epithelial and smooth muscle cell proliferation: role of Jun N‐terminal kinase British Journal of Pharmacology ·Paul R. Eynott, Puneeta Nath, Sum‐Yee Leung, Ian M. Adcock, Brydon L. Bennett, Kian Fan Chung	2003	54
9	c-Jun N-terminal kinase is required for metalloproteinase expression and joint destruction in inflammatory arthritis Journal of Clinical Investigation ·Zuoning Han, David L. Boyle, Lufen Chang, Brydon L. Bennett, Michael Karin, Yang Li, Anthony M. Manning, Gary S. Firestein	2001	49
10	Differential Role of IκB Kinase 1 and 2 in Primary Rat Hepatocytes Hepatology ·Robert F. Schwabe, Brydon L. Bennett, Anthony Manning, David A. Brenner	2001	44
11	Analysis of pharmacologic inhibitors of Jun N-terminal kinases Methods in enzymology on CD-ROM/Methods in enzymology ·Brion W. Murray, Brydon L. Bennett, Dennis T. Sasaki	2001	6
12	NF-κB Regulation by IκB Kinase-2 in Rheumatoid Arthritis Synoviocytes The Journal of Immunology ·Karlfried R. Aupperle, Brydon L. Bennett, Zuoning Han, David L. Boyle, Anthony M. Manning, Gary S. Firestein	2001	113
13	Expression and Regulation of Inducible IκB Kinase (IKK-i) in Human Fibroblast-like Synoviocytes Cellular Immunology ·Karlfried R. Aupperle, Yuji Yamanishi, Brydon L. Bennett, Frank Mercurio, David L. Boyle, Gary S. Firestein	2001	33
14	TAK1/JNK and p38 have opposite effects on rat hepatic stellate cells Hepatology ·Bernd Schnabl, Cynthia A. Bradham, Brydon L. Bennett, Anthony M. Manning, Branko Stefanovic, David A. Brenner	2001	107
15	The NF-κB Cascade Is Important in Bcl-xL Expression and for the Anti-Apoptotic Effects of the CD28 Receptor in Primary Human CD4+ Lymphocytes The Journal of Immunology ·Ali Khoshnan, Charles Tindell, Isett Laux, D. Bae, Brydon L. Bennett, André E. Nel	2000	194
16	NF-κB Regulation by IκB Kinase in Primary Fibroblast-Like Synoviocytes The Journal of Immunology ·Karlfried R. Aupperle, Brydon L. Bennett, David L. Boyle, Paul‐Peter Tak, Anthony M. Manning, Gary S. Firestein	1999	87
17	Signaling by proinflammatory cytokines: oligomerization of TRAF2 and TRAF6 is sufficient for JNK and IKK activation and target gene induction via an amino-terminal effector domain Genes & Development ·Véronique Baud, Zhanguo Liu, Brydon L. Bennett, Nobutaka Suzuki, Ying Xia, Michael Karin	1999	401
18	Role of IKK1 and IKK2 in Lipopolysaccharide Signaling in Human Monocytic Cells Journal of Biological Chemistry ·Maria A. O’Connell, Brydon L. Bennett, Frank Mercurio, Anthony M. Manning, Nigel Mackman	1998	172
19	Selective inhibition of TNF-αinduced cell adhesion molecule gene expression by tanapox virus Microbial Pathogenesis ·Mini Paulose, Brydon L. Bennett, Anthony M. Manning, Karim Essani	1998	18
20	Interleukin-4 Suppression of Tumor Necrosis Factor α-stimulated E-selectin Gene Transcription Is Mediated by STAT6 Antagonism of NF-κB Journal of Biological Chemistry ·Brydon L. Bennett, Rebecca Cruz, Raul Lacson, Anthony M. Manning	1997	128

About Brydon L. Bennett

Brydon L. Bennett is a scholar working on Cancer Research, Immunology, Pharmacology, Oncology and Pathology and Forensic Medicine, having authored 62 papers that have together received 8.8k indexed citations. Recurring topics across this work include NF-κB Signaling Pathways (23 papers), Melanoma and MAPK Pathways (16 papers), Cytokine Signaling Pathways and Interactions (13 papers), Immune Response and Inflammation (11 papers), Drug-Induced Hepatotoxicity and Protection (7 papers), Cell death mechanisms and regulation (7 papers), Natural product bioactivities and synthesis (5 papers) and Immune Cell Function and Interaction (4 papers). The work is most often cited by research in Cancer Research (3.1k citations), Immunology (3.0k citations), Oncology (1.8k citations), Molecular Biology (4.5k citations) and Pharmacology (424 citations). Brydon L. Bennett has collaborated with scholars based in United States, Switzerland and Japan. Frequent co-authors include Anthony M. Manning, Brion W. Murray, Frank Mercurio, Yoshitaka Satoh, David L. Boyle, David B. Young, Andrej Shevchenko, Matthias Mann, Hengyi Zhu and Weiming Xu. Their work appears in journals such as The Journal of Immunology, Journal of Biological Chemistry, Transplantation, Blood and Journal of Clinical Investigation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact